The World Health Organisation (WHO) could soon reveal the first details of its global strategy to bring low-cost HIV/AIDS drugs to 3 million people in developing countries by 2005.
WHO officials in Geneva recently confirmed that the plan could also eventually include the endorsement of pills that combine three anti-HIV/AIDS drugs in a single dose.
In a recent interview with the Washington Post newspaper, the director of the HIV/AIDS department at WHO, Paulo Teixeira, said: "If we have this regimen in fixed-dose combinations, it will be the best. I hope very soon we will have more and more fixed-dose combinations."
The single-pill combinations, which are already being sold by a generic-drug manufacturer in India, are expected to offer huge benefits to about 80 percent of people living with HIV/AIDS in developing countries, by providing them with medication in an easy-to-use, low-cost form.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions
Share this article
